Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study)

    The oral gonadotropin-releasing hormone antagonist relugolix, which temporarily stops menstruation, is used to treat heavy menstrual bleeding, pelvic pressure, and low back pain in women with uterine fibroids....

    Mari Kitade, Jun Kumakiri, Hiroyuki Kobori, Keisuke Murakami in Trials (2024)

  2. Article

    Melatonin in chronic kidney disease: a promising chronotherapy targeting the intrarenal renin–angiotensin system

    Asadur Rahman, Arif Ul Hasan, Hiroyuki Kobori in Hypertension Research (2019)

  3. No Access

    Article

    Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats

    Herein, we studied the effects of the novel nonsteroidal selective mineralocorticoid receptor (MR) blocker, esaxerenone, on blood pressure and renal injury in Dahl salt-sensitive (DSS) rats. We also monitored ...

    Lei Li, Yu Guan, Hiroyuki Kobori, Asahiro Morishita, Hideki Kobara in Hypertension Research (2019)

  4. Article

    Open Access

    Independent regulation of renin–angiotensin–aldosterone system in the kidney

    Renin–angiotensin–aldosterone system (RAAS) plays important roles in regulating renal hemodynamics and functions, as well as in the pathophysiology of hypertension and renal disease. In the kidney, angiotensin...

    Akira Nishiyama, Hiroyuki Kobori in Clinical and Experimental Nephrology (2018)

  5. Article

    Intrarenal renin-angiotensin system activation in end-stage renal disease

    Maki Urushihara, Hiroyuki Kobori in Hypertension Research (2017)

  6. Article

    Open Access

    Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats

    Recent clinical studies have shown that renal sympathetic denervation (RDX) improves glucose metabolism in patients with resistant hypertension. We aimed to elucidate the potential contribution of the renal sy...

    Kazi Rafiq, Yoshihide Fujisawa, Shamshad J. Sherajee, Asadur Rahman in Diabetologia (2015)

  7. No Access

    Article

    Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial

    Several studies have demonstrated that spironolactone has an anti-albuminuric property in diabetic nephropathy. As an adverse event, spironolactone often induces the elevation of creatinine levels with hypoten...

    Sawako Kato, Shoichi Maruyama, Hirofumi Makino in Clinical and Experimental Nephrology (2015)

  8. No Access

    Article

    Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients

    Recently, we demonstrated that urinary angiotensinogen (AGT) levels are increased and reflect intrarenal renin–angiotensin system (RAS) status in pediatric patients with chronic glomerulonephritis. Therefore, ...

    Maki Urushihara, Takashi Nagai, Yukiko Kinoshita, Sato Nishiyama in Pediatric Nephrology (2015)

  9. Article

    Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats

    A growing body of evidence has indicated that dipeptidyl peptidase-4 (DPP-4) inhibitors have antihypertensive effects. Here, we aim to examine the effect of vildagliptin, a DPP-4-specific inhibitor, on blood p...

    Abu Sufiun, Kazi Rafiq, Yoshihide Fujisawa, Asadur Rahman in Hypertension Research (2015)

  10. Article

    Open Access

    (Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma

    Although Wnt/β-catenin signaling is known to be aberrantly activated in PDAC, mutations of CTNNB1, APC or other pathway components are rare in this tumor type, suggesting alternative mechanisms for Wnt/β-catenin ...

    Yuki Shibayama, Takayuki Fujimori, Genevieve Nguyen, Takuo Hirose in Scientific Reports (2015)

  11. Article

    Serum soluble (pro)renin receptor levels in patients with essential hypertension

    The (pro)renin receptor ((P)RR) is expressed in several tissues including kidney, heart and brain, and is thought to regulate the tissue renin–angiotensin system (RAS) through the non-proteolytic activation of...

    Satoshi Morimoto, Takashi Ando, Michita Niiyama, Yasufumi Seki in Hypertension Research (2014)

  12. Article

    Liver-specific angiotensinogen suppression: an old yet novel target for blood pressure control through RAS inhibition?

    Kento Kitada, Hiroyuki Kobori, Akira Nishiyama in Hypertension Research (2014)

  13. Article

    High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1/2-dependent pathway

    Angiotensin II (Ang II)-induced vascular injury is exacerbated by high-salt diets. This study examined the effects of high-sodium level on Ang II-induced cell proliferation in rat vascular smooth muscle cells ...

    Gang Liu, Hirofumi Hitomi, Asadur Rahman, Daisuke Nakano in Hypertension Research (2014)

  14. Article

    The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

    Accumulated evidence suggests that an altered ambulatory blood pressure (BP) profile, particularly elevated nighttime BP, reflects target organ injury and is a better predictor of further cardiorenal risk than...

    Mai Yanagi, Kouichi Tamura, Tetsuya Fujikawa, Hiromichi Wakui in Hypertension Research (2013)

  15. No Access

    Article

    Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease

    Activated intrarenal renin–angiotensin system plays a cardinal role in the pathogenesis of hypertension and chronic kidney disease. Angiotensinogen is the only known substrate for renin, which is the rate-limi...

    Hiroyuki Kobori, Maki Urushihara in Pflügers Archiv - European Journal of Physiology (2013)

  16. No Access

    Article

    The Link Between the Renin-Angiotensin-Aldosterone System and Renal Injury in Obesity and the Metabolic Syndrome

    Obesity is a risk factor for type 2 diabetes mellitus (DM) and is associated with chronic kidney disease. Activation of the renin-angiotensin-aldosterone system (RAAS) is common in obesity. The RAAS is an impo...

    Tina Thethi, Masumi Kamiyama, Hiroyuki Kobori in Current Hypertension Reports (2012)

  17. Article

    Regulation of a novel angiotensin II precursor, proangiotensin-12, in the tissues by blockade of the renin–angiotensin system

    Ryousuke Satou, Hiroyuki Kobori in Hypertension Research (2012)

  18. Article

    Rho-kinase/nuclear factor-κβ/angiotensinogen axis in angiotensin II-induced renal injury

    Hiroyuki Kobori, Yuri Ozawa, Omar W Acres, Kayoko Miyata in Hypertension Research (2011)

  19. No Access

    Chapter

    Renin-Angiotensin System in the Kidney and Oxidative Stress: Local Renin-Angiotensin-Aldosterone System and NADPH Oxidase-Dependent Oxidative Stress in the Kidney

    The renin-angiotensin system (RAS) plays an important role in the pathogenesis of renal diseases. All of the RAS components can be found in the kidney, and intrarenal angiotensin II (AngII) is formed by multip...

    Hideyasu Kiyomoto, Hiroyuki Kobori, Akira Nishiyama in Studies on Renal Disorders (2011)

  20. Article

    Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species—ERK/JNK pathways

    Whereas intra-renal angiotensinogen is predominantly localized in proximal tubular cells under basal conditions, it has been previously reported that angiotensinogen expression is induced in glomeruli under pa...

    Naro Ohashi, Maki Urushihara, Ryousuke Satou, Hiroyuki Kobori in Hypertension Research (2010)

previous disabled Page of 2